1. Home
  2. BNR vs MCRB Comparison

BNR vs MCRB Comparison

Compare BNR & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$9.67

Market Cap

76.5M

Sector

Health Care

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$7.60

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
MCRB
Founded
2014
2010
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.5M
71.0M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
BNR
MCRB
Price
$9.67
$7.60
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.00
AVG Volume (30 Days)
20.8K
107.2K
Earning Date
06-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$789,000.00
Revenue This Year
$111.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.51
$5.31
52 Week High
$41.72
$29.98

Technical Indicators

Market Signals
Indicator
BNR
MCRB
Relative Strength Index (RSI) 49.24 57.53
Support Level $8.05 $6.56
Resistance Level $9.90 $9.53
Average True Range (ATR) 0.82 0.62
MACD 0.52 0.19
Stochastic Oscillator 84.46 84.55

Price Performance

Historical Comparison
BNR
MCRB

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: